Screening for participants in the ISCHEMIA trial: Implications for clinical research is a research paper published in Journal of Clinical and Translational Science (2022). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NHLBI NIH HHS
Grant: K01 HL144607
NHLBI NIH HHS
Grant: U01 HL105907
National Institutes of Health
Grant: 4U01HL105561-05
The ISCHEMIA Trial - IICC
National Institutes of Health
Grant: 4U01HL105462-05
The ISCHEMIA Trial - SDCC
National Institutes of Health
Grant: 5U01HL105565-03
The ISCHEMIA Trial - EQOL
National Institutes of Health
Grant: 3U01HL105907-02S1
The Ischemia Trial - CCC
Fields of Study
Keywords
Sustainable Development Goals